Vitamin D, Albumin, and D-Dimer as Significant Prognostic Markers in Early Hospitalization in Patients with COVID-19

SARS-CoV-2 continues to pose a major challenge to scientists and clinicians. We examined the significance of the serum concentrations of vitamin D, albumin, and D-dimer for the severity of the clinical picture and mortality in COVID-19. Materials and methods: A total of 288 patients treated for COVID-19 infection participated in the research. The patients were treated in the period from May 2020 to January 2021. All patients were divided based on the need for oxygen therapy (Sat > 94%) into patients with mild or severe clinical pictures. The biochemical and radiographic parameters of the patients were analyzed. Appropriate statistical methods were used in the statistical analysis. Results: In patients with COVID-19 with confirmed severe clinical pictures, lower values of serum albumin (p < 0.0005) and vitamin D (p = 0.004) were recorded, as opposed to elevated values of D-dimer (p < 0.0005). Accordingly, the patients with fatal disease outcomes had lower levels of albumin (p < 0.0005) and vitamin D (p = 0.002), while their D-dimer (p < 0.0005) levels were elevated. An increase in the radiographic score, as a parameter for assessing the severity of the clinical picture, was accompanied by a decrease in serum albumin (p < 0.0005) and a simultaneous increase in D-dimer (p < 0.0005), without a change in the vitamin D concentration (p = 0.261). We also demonstrated the interrelations of the serum levels of vitamin D, albumin, and D-dimer in patients with COVID-19 as well as their significance as predictors of the outcome of the disease. Conclusion: The significance of the predictive parameters in our study indicates the existence of an important combined role of vitamin D, albumin, and D-dimer in the early diagnosis of the most severe patients suffering from COVID-19. Reduced values of vitamin D and albumin, in combination with elevated values of D-dimer, can be timely indicators of the development of a severe clinical picture and death due to COVID-19.

[1]  Arslan Senol.  The ability of D-dimer, albumin, and D-Dimer/albumin ratio to predict in-hospital mortality and intensive care unit admission in COVID-19 patients admitted to the emergency department. , 2022, Bratislavske lekarske listy.

[2]  A. di Masi,et al.  The Impact of Serum Albumin Levels on COVID-19 Mortality , 2022, Infectious disease reports.

[3]  F. Silvagno,et al.  The Role of Vitamin D in Supporting Health in the COVID-19 Era , 2022, International journal of molecular sciences.

[4]  J. Veličković,et al.  D-dimer, CRP, PCT, and IL-6 Levels at Admission to ICU Can Predict In-Hospital Mortality in Patients with COVID-19 Pneumonia , 2022, Oxidative medicine and cellular longevity.

[5]  Sirajudheen Anwar,et al.  The Impact of COVID-19 On Comorbidities: A Review Of Recent Updates For Combating It , 2022, Saudi Journal of Biological Sciences.

[6]  Omar Yaxmehen Bello-Chavolla,et al.  Serum Vitamin D Levels Are Associated With Increased COVID-19 Severity and Mortality Independent of Whole-Body and Visceral Adiposity , 2022, Frontiers in Nutrition.

[7]  M. Yousefi,et al.  Serum levels of vitamin D and immune system function in patients with COVID-19 admitted to intensive care unit , 2022, Gene Reports.

[8]  S. Hernández-Jiménez,et al.  Very Low Vitamin D Levels are a Strong Independent Predictor of Mortality in Hospitalized Patients with Severe COVID-19 , 2021, Archives of Medical Research.

[9]  E. Denova-Gutiérrez,et al.  Total, Bioavailable, and Free 25-Hydroxyvitamin D Equally Associate with Adiposity Markers and Metabolic Traits in Mexican Adults , 2021, Nutrients.

[10]  I. Kostić,et al.  Severity of SARS-CoV-2 infection and albumin levels recorded at the first emergency department evaluation: a multicentre retrospective observational study , 2021, Emergency Medicine Journal.

[11]  B. Aryal,et al.  D-dimer as a biomarker for assessment of COVID-19 prognosis: D-dimer levels on admission and its role in predicting disease outcome in hospitalized patients with COVID-19 , 2021, PloS one.

[12]  S. Matin,et al.  The sufficient vitamin D and albumin level have a protective effect on COVID-19 infection , 2021, Archives of Microbiology.

[13]  H. Hartono,et al.  Prognostic properties of hypoalbuminemia in COVID-19 patients: A systematic review and diagnostic meta-analysis , 2021, Clinical Nutrition ESPEN.

[14]  P. Mehta,et al.  Is severe COVID-19 a cytokine storm syndrome: a hyperinflammatory debate , 2021, Current opinion in rheumatology.

[15]  P. Liao,et al.  Serum Albumin Levels are a Predictor of COVID-19 Patient Prognosis: Evidence from a Single Cohort in Chongqing, China , 2021, International journal of general medicine.

[16]  K. Sridharan,et al.  Evaluation of serum vitamin D levels in COVID-19 positive critically ill adults , 2021 .

[17]  A. S. Girişgin,et al.  Predictive value of D‐dimer/albumin ratio and fibrinogen/albumin ratio for in‐hospital mortality in patients with COVID‐19 , 2021, International journal of clinical practice.

[18]  Tanusree Sengupta,et al.  Role of vitamin D in treating COVID-19-associated coagulopathy: problems and perspectives , 2021, Molecular and Cellular Biochemistry.

[19]  A. Islam,et al.  Potential drug targets of SARS-CoV-2: From genomics to therapeutics , 2021, International Journal of Biological Macromolecules.

[20]  I. Nuñez-Gil,et al.  Hypoalbuminemia on admission in COVID-19 infection: An early predictor of mortality and adverse events. A retrospective observational study , 2021, Medicina Clínica.

[21]  G. d’Ettorre,et al.  Albumin Supplementation Dampens Hypercoagulability in COVID-19: A Preliminary Report , 2020, Thrombosis and Haemostasis.

[22]  H. Goyal,et al.  Clinical Characteristics, Diagnosis, and Treatment of Major Coronavirus Outbreaks , 2020, Frontiers in Medicine.

[23]  Marcos Pereira,et al.  Vitamin D deficiency aggravates COVID-19: systematic review and meta-analysis , 2020, Critical reviews in food science and nutrition.

[24]  Hyeyoung Kim,et al.  The Role of Vitamin C, Vitamin D, and Selenium in Immune System against COVID-19 , 2020, Molecules.

[25]  H. Mansouritorghabeh,et al.  D-dimer level in COVID-19 infection: a systematic review , 2020, Expert review of hematology.

[26]  H. Biesalski.  Obesity, vitamin D deficiency and old age a serious combination with respect to coronavirus disease-2019 severity and outcome , 2020, Current opinion in clinical nutrition and metabolic care.

[27]  F. Ozturk,et al.  Elevated D-dimer levels on admission are associated with severity and increased risk of mortality in COVID-19: A systematic review and meta-analysis , 2020, The American Journal of Emergency Medicine.

[28]  M. Holick,et al.  Reply to Jakovac and to Rocha et al.: Can vitamin D prevent or manage COVID-19 illness? , 2020, American journal of physiology. Endocrinology and metabolism.

[29]  T. Flanigan,et al.  Predictors of COVID‐19 severity: A literature review , 2020, Reviews in medical virology.

[30]  M. I. Hassan,et al.  Identification of high-affinity inhibitors of SARS-CoV-2 main protease: Towards the development of effective COVID-19 therapy , 2020, Virus Research.

[31]  M. Panteghini,et al.  Hypoalbuminemia and elevated D-dimer in COVID-19 patients: a call for result harmonization , 2020, Clinical chemistry and laboratory medicine.

[32]  S. Singh,et al.  Vitamin D deficiency in patients with diabetes and COVID- 19 infection , 2020, Diabetes & Metabolic Syndrome: Clinical Research & Reviews.

[33]  S. Urcuqui-Inchima,et al.  Vitamin D Supplementation: A Potential Approach for Coronavirus/COVID-19 Therapeutics? , 2020, Frontiers in Immunology.

[34]  E. K. Weir,et al.  Does vitamin D deficiency increase the severity of COVID-19? , 2020, Clinical medicine.

[35]  Asimul Islam,et al.  Glecaprevir and Maraviroc are high-affinity inhibitors of SARS-CoV-2 main protease: possible implication in COVID-19 therapy , 2020, Bioscience reports.

[36]  Jiaofeng Huang,et al.  Hypoalbuminemia predicts the outcome of COVID‐19 independent of age and co‐morbidity , 2020, Journal of medical virology.

[37]  R. Kenny,et al.  Vitamin D and Inflammation: Potential Implications for Severity of Covid-19. , 2020, Irish medical journal.

[38]  P. Velagapudi,et al.  Elevated D-Dimer Levels are Associated with Increased Risk of Mortality in COVID-19: A Systematic Review and Meta-Analysis , 2020, medRxiv.

[39]  R. Maroldi,et al.  COVID-19 outbreak in Italy: experimental chest X-ray scoring system for quantifying and monitoring disease progression , 2020, La radiologia medica.

[40]  W. Grant,et al.  Evidence that Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and Deaths , 2020, Nutrients.

[41]  E. Holmes,et al.  The proximal origin of SARS-CoV-2 , 2020, Nature Medicine.

[42]  A. Jan,et al.  BMI Classification Percentile And Cut Off Points , 2019 .

[43]  M. Z. Ashraf,et al.  Emerging Role of Vitamin D and its Associated Molecules in Pathways Related to Pathogenesis of Thrombosis , 2019, Biomolecules.

[44]  Ravinder J. Singh,et al.  Obesity Decreases Hepatic 25‐Hydroxylase Activity Causing Low Serum 25‐Hydroxyvitamin D , 2019, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[45]  F. Shokri,et al.  The interplay between vitamin D and viral infections , 2019, Reviews in medical virology.

[46]  David A. Jolliffe,et al.  Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data , 2017, British Medical Journal.

[47]  Xiaohua Duan,et al.  Bioavailable 25(OH)D but Not Total 25(OH)D Is an Independent Determinant for Bone Mineral Density in Chinese Postmenopausal Women , 2016, EBioMedicine.

[48]  Alimuddin Zumla,et al.  Coronaviruses — drug discovery and therapeutic options , 2016, Nature Reviews Drug Discovery.

[49]  C. Ronco,et al.  Pro-inflammatory cytokines: a possible relationship with dialytic adequacy and serum albumin in peritoneal dialysis patients , 2015, Clinical kidney journal.

[50]  M. Huisman,et al.  The use of D-dimer in specific clinical conditions: a narrative review. , 2009, European journal of internal medicine.

[51]  M. Folic,et al.  Significance of initial clinical - laboratory parameters as prognostic factors in patients with COVID 19 , 2022, Vojnosanitetski pregled.